FLZ, synthetic squamosamide cyclic derivative, attenuates memory deficit and pathological changes in mice with experimentally induced aging

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 6, 2012, Pages 579-585

  Fang, Fang ^a,b   Wang, Qing Li ^a   Liu, Geng Tao ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Compound FLZ; D galactose; Memory deficit; NaNO 2

Indexed keywords

ACETYLCHOLINESTERASE; ACRYLAMIDE DERIVATIVE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIOXIDANT; CHOLINE ACETYLTRANSFERASE; GALACTOSIDE; GLUTATHIONE PEROXIDASE; HERBACEOUS AGENT; MALONALDEHYDE; N[ 2 (4 HYDROXY PHENYL)ETHYL] 2 (2,5 DIMETHOXY PHENYL) 3 (3 METHOXY 4 HYDROXY PHENYL)ACRYLAMIDE; NOOTROPIC AGENT; SODIUM NITRITE; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN LEVEL; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME ACTIVATION; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; MALE; MEMORY DISORDER; MENTAL TASK; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SENESCENCE;

AGING; ANIMALS; AVOIDANCE LEARNING; BENZENEACETAMIDES; BRAIN; DISEASE MODELS, ANIMAL; GALACTOSE; GLUTATHIONE PEROXIDASE; MALE; MALONDIALDEHYDE; MEMORY DISORDERS; MICE; MICE, INBRED ICR; MONOAMINE OXIDASE; NEURONS; NEUROPROTECTIVE AGENTS; PHENOLS; SODIUM NITRITE;

EID: 84862890285     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0745-z     Document Type: Article

References (33)

1. Bar-Am O, Weinreb O, Amit T, Youdim MB (2009) The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats. J Mol Neurosci 37:135-145
2. Cui X, Li WB, Zhang BL, Cai YS, Sun JB (2000) Studies on the relationship between cell senescence induced by D-galactose and injuries effects of free radical. Basci Medical Sciences and Clinics 20:24-26
3. Cui X, Zuo PP, Zhang Q, Li X, Hu Y, Long J, Packer L, Liu J (2006) Chronic systemic D-galactose exposure induces memory loss, neurodegeneration and oxidation damage in mice: protective effects of R-α-lipoic acid. J Neurosci Res 84:647-654 (Pubitemid 44196705)
4. Darinka SD, Damianka PG (2006) Effects of galantamine and done-pezil on active and passive avoidance tests in rats with induced hypoxia. J Pharmacol Sci 101:199-204
5. Deng HB, Cheng CL, Cui DP, Li DD, Cui L, Cai NS (2006) Structural and functional changes of immune system in aging mouse induced by D-galactose. Biomed Environ Sci 19:432-438 (Pubitemid 46325270)
6. Fang F, Liu GT (2006) Protective effects of compound FLZ on β-amyloid peptide-(25-35)-induced mouse hippocampal injury and learning and memory impairment. Acta Pharmacol Sin 27:651-658 (Pubitemid 43943911)
7. Fang F, Liu GT (2008) Novel squamosamide derivative (compound FLZ) attenuates Aß25-35-induced toxicity in SH-SY5Y cell. Acta Pharmacologica Sinica 29:152-160 (Pubitemid 351178418)
8. Farooqui T, Farooqui AA (2009) Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 130:203-215
9. Feng W, Wei H, Liu G (2005) Pharmacological study of the novel compound FLZ against experimental Parkinson's models and its active mechanism. Mol Neurobiol 31:295-300 (Pubitemid 41271210)
10. Floyd RA, Hensley K (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23:795-807 (Pubitemid 35217704)
11. Fratiglioni L, Qiu C (2009) Prevention of common neurodegenerative disorders in the elderly. Exp Gerontol 44:46-50
12. Gilgun-Sherki Y, Melamed E, Offen D (2001) Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacolog 40:959-975 (Pubitemid 32530602)
13. Ho YS, So KF, Chang RC (2010) Anti-aging herbal medicine - how and why can they be used in aging-associated neurodegenerative diseases? Ageing Res Rev 9:354-362
14. Klimmek R, Krettek C, Werner HW (1998) Ferrihaemogolbin formation by amyl nitrite and sodium nitrite in different species in vivo and in vitro. Arch Toxicol 62:152-160
15. Lei M, Hua X, Xiao M, Ding J, Han Q, Hu G (2008a) Impairments of astrocytes are involved in the D-galactose-induced brain aging. Biochem Biophys Res Commun 369:1082-1087
16. Lei M, Su Y, Hua X, Ding J, Han Q, Hu G, Xiao M (2008b) Chronic systemic injection of D-galactose impairs the septohippocampal cholinergic system in rats. NeuroReport 19:1611-1615
17. Liu A, Ma Y, Zhu Z (2009) Protective effect of selenoarginine against oxidative stress in D-galactose-induced aging mice. Biosci Bio-technol Biochem 73:1461-1464
18. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
19. Mishra OP, Zanelli S, Ohnishi ST, Delivoria-Papadopoulos M (2000) Hypoxia-induced generation of nitric oxide free radicals in cerebral cortex of newborn guinea pigs. Neurochem Res 25:1559-1565 (Pubitemid 32052017)
20. Muir JL (1997) Acetylcholine, aging, and Alzheimer's disease. Pharmacol Biochem Behav 56:687-696 (Pubitemid 27189754)
21. Nicotra A, Pierucci F, Parvez H, Senatori O (2004) Monoamine oxi-dase expression during development and aging. NeuroToxicology 25:155-165 (Pubitemid 38044177)
22. Rosenzweig ES, Barnes CA (2003) Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog Neurobiol 69:143-179 (Pubitemid 36577321)
23. Troulinaki K, Tavernarakis N (2005) Neurodegenerative conditions associated with ageing: a molecular interplay? Mech Ageing Dev 126:23-33 (Pubitemid 40018474)
24. Wei HF, Li L, Song QJ, Ai HH, Chu J, Li W (2005) Behavioral study of the D-galactose induced aging model in C57BL/6 L mice. Behav Brain Res 157:245-251 (Pubitemid 40082567)
25. Weinreb O, Bar-Am O, Amit T, Drigues N, Sagi Y, Youdim MB (2008) The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity. Chem Biol Interact 175:318-326
26. Wilson RS, Li Y, Aggarwal NT, McCann JJ, Gilley DW, Bienias JL et al (2006) Cognitive decline and survival in Alzheimer's disease. Int J Geriatr Psychiatr 21:356-362
27. Xie P, Jiao XZ, Liang XT, Feng WH, Wei HL, Liu GT (2004) Synthesis and antioxiactivity of squamosamide cyclic analogs. Acta Academiae Medicinae Sinicae 26:372-378
28. Zekry D, Epperson TK, Krause KH (2003) A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia? IUBMB Life 55:307-313 (Pubitemid 36975540)
29. Zhang D, Liu GT, Shi JG, Zhang JJ (2006) Coeloglossum viride var. bracteatum extract attenuates D-galactose and NaNO2 induced memory impairment in mice. J Ethnoparmacol 104:250-256 (Pubitemid 43234112)
30. Zhang D, Zhang JJ, Liu GT (2007) The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP (+))-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells. Neuropharmacology 52:423-429 (Pubitemid 46123358)
31. Zhang D, Hu X, Wei SJ, Liu J, Gao H, Qian L, Wilson B, Liu G, Hong JS (2008) Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity. J Neuroinflammation 28:21-28
32. Zhong SZ, Ge QH, Qu R, Li Q, Ma SP (2009) Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by D-galactose in ICR mice. J Neurol Sci 277:58-64
33. Zhu YZ, Zhu HG (2007) Establishment and measurement of D-galactose induced aging model. Fudan Univ J Med Sci 34:617-619